½ÃÀ庸°í¼­
»óǰÄÚµå
1360300

¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ÄÁÅ×ÀÌ³Ê ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2023-2033³â)

Bioprocess Containers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Transparency Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 201 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ÄÁÅ×ÀÌ³Ê ½ÃÀå - ¸®Æ÷Æ®ÀÇ ¹üÀ§

¼¼°èÀÇ ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ÄÁÅ×ÀÌ³Ê ½ÃÀå¿¡ °üÇÑ TMRÀÇ ¸®Æ÷Æ®´Â °ú°Å¿Í ÇöÀçÀÇ ¼ºÀå µ¿Çâ ¹× 2023-2033³âÀÇ ¿¹Ãø ±â°£ Áß ½ÃÀå ÁöÇ¥ÀÇ ±ÍÁßÇÑ ÀλçÀÌÆ®¸¦ ¾òÀ» ±âȸ¸¦ ¿¬±¸Çϰí ÀÖ½À´Ï´Ù. ¸®Æ÷Æ®´Â ¼¼°èÀÇ ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ÄÁÅ×ÀÌ³Ê ½ÃÀåÀÇ ¸ÅÃâÀ» Á¦°øÇÕ´Ï´Ù. 2017-2033³â ±â°£, 2023³âÀ» ±âÁسâ, 2033³âÀ» ¿¹Ãø³âÀ¸·Î °£ÁÖÇÕ´Ï´Ù. ÀÌ ¸®Æ÷Æ®´Â 2023-2033³â ¼¼°èÀÇ ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ÄÁÅ×ÀÌ³Ê ½ÃÀåÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR %)µµ Á¦°øÇÕ´Ï´Ù.

ÀÌ ¸®Æ÷Æ®´Â ±¤¹üÀ§ÇÑ Á¶»ç¸¦ °ÅÃÄ ÀÛ¼ºµÇ¾ú½À´Ï´Ù. 1Â÷ Á¶»ç¿¡¼­´Â Á¶»ç Ȱµ¿ÀÇ ´ëºÎºÐÀÌ ½ÃÇàµÇ°í, ¾Ö³Î¸®½ºÆ®°¡ ÁÖ¿ä ¿ÀÇǴϾ𠸮´õ, ¾÷°è ¸®´õ, ¿ÀÇǴϾð Á¦Á¶¾÷ü¿Í ÀÎÅͺ並 ÁøÇàÇß½À´Ï´Ù. 2Â÷ Á¶»ç¿¡´Â ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ÄÁÅ×ÀÌ³Ê ½ÃÀåÀ» ÀÌÇØÇϱâ À§ÇØ ÁÖ¿ä ±â¾÷ÀÇ Á¦Ç° ¹®Çå, ¿¬Â÷º¸°í¼­, ÇÁ·¹½º ¸±¸®½º ¹× °ü·Ã ¹®¼­ ÂüÁ¶°¡ Æ÷ÇԵ˴ϴÙ.

½ÃÀå ½º³À¼ô
2023³â ½ÃÀå °¡Ä¡ 29¾ï ´Þ·¯
2033³â ½ÃÀå °¡Ä¡ 93¾ï ´Þ·¯
CAGR 11.1%

ÀÌ ¸®Æ÷Æ®´Â ¼¼°èÀÇ ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ÄÁÅ×ÀÌ³Ê ½ÃÀåÀÇ °æÀï ±¸µµ¸¦ »ó¼¼ ºÐ¼®Çϰí ÀÖ½À´Ï´Ù. ¼¼°èÀÇ ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ÄÁÅ×ÀÌ³Ê ½ÃÀå¿¡¼­ Ȱµ¿Çϰí ÀÖ´Â ÁÖ¿ä ±â¾÷ÀÌ ½Äº°µÇ°í, ÀÌ °¢°¢ÀÌ ´Ù¾çÇÑ ¼Ó¼ºÀÇ Ãø¸é¿¡¼­ ÇÁ·ÎÆÄÀϸµµÇ°í ÀÖ½À´Ï´Ù. ȸ»ç °³¿ä, À繫 »óȲ, ÃÖ±Ù µ¿Çâ, SWOT´Â ÀÌ ¸®Æ÷Æ®¿¡¼­ ¼Ò°³µÇ°í ÀÖ´Â ¼¼°èÀÇ ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ÄÁÅ×ÀÌ³Ê ½ÃÀå¿¡¼­ ±â¾÷ÀÇ ¼Ó¼ºÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÀüÁ¦Á¶°Ç°ú Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à : ¼¼°è ½ÃÀå

Á¦4Àå ½ÃÀå °³¿ä

  • ¼­·Ð
  • °³¿ä
  • ½ÃÀå ¿ªÇÐ
  • ¼¼°è ½ÃÀåÀÇ ºÐ¼®°ú ¿¹Ãø, 2017-2033³â

Á¦5Àå ÁÖ¿ä ÀλçÀÌÆ®

  • ±â¼úÀÇ Áøº¸
  • ÁÖ¿ä ¾÷°è À̺¥Æ®
  • COVID-19 ÆÒµ¥¹ÍÀÇ ¾÷°è¿¡ ´ëÇÑ ¿µÇâ(¹ë·ùüÀΰú ´Ü±â¡¤Á߱⡤Àå±âÀûÀÎ ¿µÇâ)

Á¦6Àå ¼¼°è ½ÃÀåÀÇ ºÐ¼®°ú ¿¹Ãø : À¯Çüº°

  • ¼­·Ð°ú Á¤ÀÇ
  • ÁÖ¿ä ¹ß°ß°ú °³¹ß
  • ½ÃÀå ±Ý¾× ¿¹Ãø : À¯Çüº°, 2017-2033
    • 2D
    • 3D
    • ±âŸ
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : À¯Çüº°

Á¦7Àå ¼¼°è ½ÃÀåÀÇ ºÐ¼®°ú ¿¹Ãø : ¿ë·®º°

  • ¼­·Ð°ú Á¤ÀÇ
  • ÁÖ¿ä ¹ß°ß°ú °³¹ß
  • ½ÃÀå ±Ý¾× ¿¹Ãø : ¿ë·®º°, 2017-2033
    • ¼Ò·®
    • ´ë¿ë·®
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ¿ë·®º°

Á¦8Àå ¼¼°è ½ÃÀåÀÇ ºÐ¼®°ú ¿¹Ãø : ¿ëµµº°

  • ¼­·Ð°ú Á¤ÀÇ
  • ÁÖ¿ä ¹ß°ß°ú °³¹ß
  • ½ÃÀå ±Ý¾× ¿¹Ãø : ¿ëµµº°, 2017-2033
    • ¾÷½ºÆ®¸² °øÁ¤
    • ´Ù¿î½ºÆ®¸² °øÁ¤
    • ÇÁ·Î¼¼½º °³¹ß
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ¿ëµµº°

Á¦9Àå ¼¼°è ½ÃÀåÀÇ ºÐ¼®°ú ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°

  • ¼­·Ð°ú Á¤ÀÇ
  • ÁÖ¿ä ¹ß°ß°ú °³¹ß
  • ½ÃÀå ±Ý¾× ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°, 2017-2033
    • Á¦¾à ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
    • CRO¿Í CMO
    • Çмú Á¶»ç±â°ü
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

Á¦10Àå ¼¼°è ½ÃÀåÀÇ ºÐ¼®°ú ¿¹Ãø : Áö¿ªº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ½ÃÀå ±Ý¾× ¿¹Ãø : Áö¿ªº°
    • ºÏ¹Ì
    • À¯·´
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Áö¿ªº°

Á¦11Àå ºÏ¹Ì ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦12Àå À¯·´ ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦13Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦14Àå ¶óÆ¾¾Æ¸Þ¸®Ä« ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦15Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦16Àå °æÀï ±¸µµ

  • ½ÃÀå ±â¾÷ - °æÀï ¸ÅÆ®¸¯½º(±â¾÷ÀÇ °èÃþ ¹× ±Ô¸ðº°)
  • ±â¾÷º° ½ÃÀå Á¡À¯À² ºÐ¼®(2022)
  • ±â¾÷ °³¿ä
    • Sartorius AG
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Merck KGaA
    • Corning Incorporated
    • Saint-Gobain
    • Avantor, Inc.
    • Parker Hannifin Corporation
    • Entegris, Inc.
    • Lonza AG
    • Flexbiosys Inc.
    • ABEC, Inc.
    • Cellexus
KSA 23.10.25

Bioprocess Containers Market - Scope of Report

TMR's report on the global bioprocess containers market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2033. The report provides revenue of the global bioprocess containers market for the period 2017-2033, considering 2023 as the base year and 2033 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global bioprocess containers market from 2023 to 2033.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the bioprocess containers market.

Market Snapshot
Market Value in 2023US$ 2.9 Bn
Market Value in 2033US$ 9.3 Bn
CAGR11.1%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global bioprocess containers market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global bioprocess containers market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global bioprocess containers market.

The report delves into the competitive landscape of the global bioprocess containers market. Key players operating in the global bioprocess containers market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global bioprocess containers market profiled in this report.

Key Questions Answered in Global Bioprocess Containers Market Report:

  • What is the sales/revenue generated by bioprocess containers across all regions during the forecast period?
  • What are the opportunities in the global bioprocess containers market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2033?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Bioprocess Containers Market - Research Objectives and Research Approach

The comprehensive report on the global bioprocess containers market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global bioprocess containers market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2033 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global bioprocess containers market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Bioprocess Containers Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Bioprocess Containers Market Analysis and Forecast, 2017-2033
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Technological Advancements
  • 5.2. Key Industry Events
  • 5.3. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)

6. Global Bioprocess Containers Market Analysis and Forecast, by Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Type, 2017-2033
    • 6.3.1. 2D Bioprocess Containers
    • 6.3.2. 3D Bioprocess Containers
    • 6.3.3. Others
  • 6.4. Market Attractiveness Analysis, by Type

7. Global Bioprocess Containers Market Analysis and Forecast, by Capacity

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Capacity, 2017-2033
    • 7.3.1. Small Volume
    • 7.3.2. Large Volume
  • 7.4. Market Attractiveness Analysis, by Capacity

8. Global Bioprocess Containers Market Analysis and Forecast, by Application

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Application, 2017-2033
    • 8.3.1. Upstream Processes
    • 8.3.2. Downstream Processes
    • 8.3.3. Process Development
  • 8.4. Market Attractiveness Analysis, by Application

9. Global Bioprocess Containers Market Analysis and Forecast, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast, by End-user, 2017-2033
    • 9.3.1. Pharmaceutical & Biotechnology Companies
    • 9.3.2. CROs & CMOs
    • 9.3.3. Academic & Research Institutes
  • 9.4. Market Attractiveness Analysis, by End-user

10. Global Bioprocess Containers Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness Analysis, by Region

11. North America Bioprocess Containers Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Type, 2017-2033
    • 11.2.1. 2D Bioprocess Containers
    • 11.2.2. 3D Bioprocess Containers
    • 11.2.3. Others
  • 11.3. Market Value Forecast, by Capacity, 2017-2033
    • 11.3.1. Small Volume
    • 11.3.2. Large Volume
  • 11.4. Market Value Forecast, by Application, 2017-2033
    • 11.4.1. Upstream Processes
    • 11.4.2. Downstream Processes
    • 11.4.3. Process Development
  • 11.5. Market Value Forecast, by End-user, 2017-2033
    • 11.5.1. Pharmaceutical & Biotechnology Companies
    • 11.5.2. CROs & CMOs
    • 11.5.3. Academic & Research Institutes
  • 11.6. Market Value Forecast, by Country, 2017-2033
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Type
    • 11.7.2. By Capacity
    • 11.7.3. By Application
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Bioprocess Containers Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Type, 2017-2033
    • 12.2.1. 2D Bioprocess Containers
    • 12.2.2. 3D Bioprocess Containers
    • 12.2.3. Others
  • 12.3. Market Value Forecast, by Capacity, 2017-2033
    • 12.3.1. Small Volume
    • 12.3.2. Large Volume
  • 12.4. Market Value Forecast, by Application, 2017-2033
    • 12.4.1. Upstream Processes
    • 12.4.2. Downstream Processes
    • 12.4.3. Process Development
  • 12.5. Market Value Forecast, by End-user, 2017-2033
    • 12.5.1. Pharmaceutical & Biotechnology Companies
    • 12.5.2. CROs & CMOs
    • 12.5.3. Academic & Research Institutes
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2033
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Type
    • 12.7.2. By Capacity
    • 12.7.3. By Application
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Bioprocess Containers Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Type, 2017-2033
    • 13.2.1. 2D Bioprocess Containers
    • 13.2.2. 3D Bioprocess Containers
    • 13.2.3. Others
  • 13.3. Market Value Forecast, by Capacity, 2017-2033
    • 13.3.1. Small Volume
    • 13.3.2. Large Volume
  • 13.4. Market Value Forecast, by Application, 2017-2033
    • 13.4.1. Upstream Processes
    • 13.4.2. Downstream Processes
    • 13.4.3. Process Development
  • 13.5. Market Value Forecast, by End-user, 2017-2033
    • 13.5.1. Pharmaceutical & Biotechnology Companies
    • 13.5.2. CROs & CMOs
    • 13.5.3. Academic & Research Institutes
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2033
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Type
    • 13.7.2. By Capacity
    • 13.7.3. By Application
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America Bioprocess Containers Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Type, 2017-2033
    • 14.2.1. 2D Bioprocess Containers
    • 14.2.2. 3D Bioprocess Containers
    • 14.2.3. Others
  • 14.3. Market Value Forecast, by Capacity, 2017-2033
    • 14.3.1. Small Volume
    • 14.3.2. Large Volume
  • 14.4. Market Value Forecast, by Application, 2017-2033
    • 14.4.1. Upstream Processes
    • 14.4.2. Downstream Processes
    • 14.4.3. Process Development
  • 14.5. Market Value Forecast, by End-user, 2017-2033
    • 14.5.1. Pharmaceutical & Biotechnology Companies
    • 14.5.2. CROs & CMOs
    • 14.5.3. Academic & Research Institutes
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2033
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Type
    • 14.7.2. By Capacity
    • 14.7.3. By Application
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Bioprocess Containers Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Type, 2017-2033
    • 15.2.1. 2D Bioprocess Containers
    • 15.2.2. 3D Bioprocess Containers
    • 15.2.3. Others
  • 15.3. Market Value Forecast, by Capacity, 2017-2033
    • 15.3.1. Small Volume
    • 15.3.2. Large Volume
  • 15.4. Market Value Forecast, by Application, 2017-2033
    • 15.4.1. Upstream Processes
    • 15.4.2. Downstream Processes
    • 15.4.3. Process Development
  • 15.5. Market Value Forecast, by End-user, 2017-2033
    • 15.5.1. Pharmaceutical & Biotechnology Companies
    • 15.5.2. CROs & CMOs
    • 15.5.3. Academic & Research Institutes
  • 15.6. Market Value Forecast, by Country/Sub-region, 2017-2033
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Type
    • 15.7.2. By Capacity
    • 15.7.3. By Application
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 16.2. Market Share Analysis By Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. Sartorius AG
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Thermo Fisher Scientific Inc.
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Danaher Corporation
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Merck KGaA
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Corning Incorporated
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Saint-Gobain
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Avantor, Inc.
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Parker Hannifin Corporation
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Entegris, Inc.
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Meissner Filtration Products, Inc.
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview
    • 16.3.11. Lonza AG
      • 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.11.2. Product Portfolio
      • 16.3.11.3. Financial Overview
      • 16.3.11.4. SWOT Analysis
      • 16.3.11.5. Strategic Overview
    • 16.3.12. Flexbiosys Inc.
      • 16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.12.2. Product Portfolio
      • 16.3.12.3. Financial Overview
      • 16.3.12.4. SWOT Analysis
      • 16.3.12.5. Strategic Overview
    • 16.3.13. ABEC, Inc.
      • 16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.13.2. Product Portfolio
      • 16.3.13.3. Financial Overview
      • 16.3.13.4. SWOT Analysis
      • 16.3.13.5. Strategic Overview
    • 16.3.14. Cellexus
      • 16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.14.2. Product Portfolio
      • 16.3.14.3. Financial Overview
      • 16.3.14.4. SWOT Analysis
      • 16.3.14.5. Strategic Overview
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦